{"name":"Rion Inc.","slug":"rion-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPbzgyQUh1WGFIVjJQUUNReVgwZUhOSWU1X0ZpZW5ISGVGVk9SckFJcHFDZGphSkhyODZXTXVla1FyUVFaLUlsQ1B3blVOcExZaEN0azJNcHZ1emNnMG1jRE1kZDJVTER4cjhEdFc4ci1veER6SUdzaXVqZHl0OWRGZTlUZEJ3MlNmQjhBSjhQd3VMRzRMdEIzTDJtUTZpXy1zRWc?oc=5","date":"2026-04-01","type":"pipeline","source":"The Pharma Letter","summary":"Cyclerion Therapeutics and Korsana Biosciences to merge - The Pharma Letter","headline":"Cyclerion Therapeutics and Korsana Biosciences to merge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOZWdPemp0OGtQUVZLWmw4c3kxWlJ3VGE4ZnQ5MVNNZm5pbU5aZ0RGVks5S0QxUWJ2TmVTRkRXVEowcTRib0JBbG90Q3JPV2pBazBmNUM3U3VpSkRjMlBwY3RSNWlPU1h3S0RLN1p1eWg0UnR2eG1rSDFsM0pZWVRMMDlnc3RtTWVscnY0dFdHZXk5bE1ocHIwUUdhWGFKbG9aMWQ1a2J4VzlHS0RRNDBKM0t3QzJOVWtOUGVFNEZHZm5MYWJXNmVF?oc=5","date":"2026-04-01","type":"pipeline","source":"Contract Pharma","summary":"Korsana Biosciences and Cyclerion Therapeutics to Merge, Operate Under Korsana Name - Contract Pharma","headline":"Korsana Biosciences and Cyclerion Therapeutics to Merge, Operate Under Korsana Name","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNbG1COEdSbFNzOE05Z0dOODhBaFVvMUNqSTluVHdHS21Ld2RmUXZldjNHLVZHQVBiUXdMdkFLUnY3bWh2VjNiRnRsbmhqZkYteWJaU1VLdVZNbEU5T0F6eHlpeG1SSDVrWUZSQUZNbmRWdll2U2h4eWxydGZkRjkzVlc5dXlmaWNsa1pyS0FtWlRzVjdfQ3d3ejYxdzZQeTNpWWFSOXliUVl6d1hXc0NkV2Z4X2E4NXFfNHJqRFVTeDI2bjAzX1FmWVYwaWlsV3F0dmZZcG5xcXU0WUtKbmJmZlBZVnF6UXdtcUJr?oc=5","date":"2026-03-24","type":"pipeline","source":"Barchart.com","summary":"Rett Syndrome Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com","headline":"Rett Syndrome Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE9xRGdDT0ZYOU1IbnM2YUJmLWVhSkdPOFFRLURBRXkyODgwcW9sb3VJamwtSE5oSVVNSjk2amRZUERzVnI4ZExkT1BvSDVtYmZjNHJXVmdXUS1mVWpyX1JRZnRueUF4Z9IBa0FVX3lxTE5PZGxNNkoxakRZZHQ4Q3AxT2ZtNG91QXd3LWE1NmMyUndKNGdOSW5GSFUwbGZaUGZFRGUtUzhGUS0wS09tZlZ1a0NjMEVLN1FzT2I4WHNrR2Z5MVY2NFpldGlUU19hVmJ1N1gw?oc=5","date":"2025-11-02","type":"regulatory","source":"BioInformant","summary":"Demand for Exosome Technologies Drives Billion Dollar Price Tags - BioInformant","headline":"Demand for Exosome Technologies Drives Billion Dollar Price Tags","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQeVE1dy12QjBuSHRwSHFhel9HMUtDZldCNnlOdDlsVEN1ZXVOaVZjQ2h0SjdWdHBESVZwNmZWenNCLVFUOEZ4RXpzUS1ubXNQRklHTWJhdVpvWVhibDYtZm9qczVWeGZqZDloVGlmcm5WNUJzcWhSU3NLU1I0TmZlTEZlOFIwUGJrRjByeE1FZE85SWV2R2lNbTVIaDQ4TmI0dV90bWJkVlVBdmJoUXA4LU9IeVgtbEU?oc=5","date":"2025-09-26","type":"pipeline","source":"News-Medical","summary":"RION engages Lonza to scale manufacturing exosome based therapeutics - News-Medical","headline":"RION engages Lonza to scale manufacturing exosome based therapeutics - News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQSF93aG5nOG9Da2VNb2hVSnJVeTI1Mlc2b1o3QzhvWGxhMnRHRFZwZ2M2ZzhWeUFNX19BWU9ieUdsbXNoYUVBQ0lIazNiMGczVjM3MVV3QUMtTWFSVXZ1YmR0MXRUTk9mN0xCb19HNE9Eb0lWN1Nna2VQbWdiS2o0RzZQbnlxZW1ERnJWYUkwTXJoM3dGdjVITzNMQWlHd0pmV19RQmtORzM2LVp2cDEwR1NTZ2Fva1E?oc=5","date":"2025-09-23","type":"deal","source":"Contract Pharma","summary":"RION Partners with Lonza for Scalable Exosome-Based Drug Manufacturing - Contract Pharma","headline":"RION Partners with Lonza for Scalable Exosome-Based Drug Manufacturing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNZ0NQbGtZVmx2ZkI4MHZGajBKVVppMndNaVN5MXhfdGRQSDVoTjVTTWI2SlVRbXk2a0s3ODlheTE0MzBab3FVV1ZlUmJsLUw4RkNwd0RtY3BXR3I0NmQxbkF2Q1hPWlQycGppYm1JTW1YRFlESE1xRFJoNFVTdDBRRjJMbFl4YzB0TGVsTA?oc=5","date":"2025-09-09","type":"pipeline","source":"Yahoo Finance","summary":"RION Launches INTENT Biologics to Develop Late-Stage Clinical Exosome-Based Therapies in Inflammation & Immunology; Appoints Biopharma Veteran Suneet Varma as CEO - Yahoo Finance","headline":"RION Launches INTENT Biologics to Develop Late-Stage Clinical Exosome-Based Therapies in Inflammation & Immunology; Appo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxNb2NTY0pNRkxiOFBoNEFoMTRKcUw2MkpvU0JRbnJLTVBKUEhha2plZmd2X3VsRFFzZnpla05Falh3QWJTX3ByanJXSjJxMjJRRDB5TUVFeVROdHdQMWUtYXhiZFhYZkpxRGxPUE4tTzVaaEl4TkNiWDMtSnNzNEhXSjRwZHhMSkdPMWJoUEFBQWZudklDTW9TWXgtQVBRZEdnczRRa3REZUxhMXFmLXZIb05tOW5ES292a0oxQXVJODVrejJuZFBCNEZCa2ZnNUdDNjhrMExlalhBcTlqVG5DZkRXYXRtV2dfTzFJM0VHcDFBUW9aMDhaLVNBWXVxUHhHNFJ1X0pIZ3FmNlNTc05aNVRsY3BfQQ?oc=5","date":"2025-06-03","type":"trial","source":"businesswire.com","summary":"Rion Aesthetics Supports Initiation of the First U.S. Investigator-Initiated Clinical Trial of Dermal Injections with PEP™ Exosomes - businesswire.com","headline":"Rion Aesthetics Supports Initiation of the First U.S. Investigator-Initiated Clinical Trial of Dermal Injections with PE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxQRHZuWnRKMWNTZGxjckVZQ25EM1FHMUt5WklIcmI0c3NOcHJTeVNia1kxb2FJZ005OElrNndZZFJfX2U5Qk1qT0tCNHdlc2FZZ24zMDhDYXNnY3U4RW1XUmJvWXNWeUp5ZzRpVkpsWE5xRTFEVExhbVJ0MzlLVFU5ZURKYUp1RHZRbnY1eGNJbGNDUVBrdFlsZDZhcV9JTlE1cG0zblRzcl85cDFUaGVDMlpBQnVOX2hPdjBRa2drelJHYk1xdXJ1cEZBUkxTbHYwU0QzZmZnWUNISjdRN3R4X19RMnFpb2VZVl93alFVZlN6SEt5d1lSVzBFVXZtU0E?oc=5","date":"2025-05-01","type":"pipeline","source":"businesswire.com","summary":"RION names Biopharma Veteran Suneet Varma as Senior Advisor to Spearhead Expansion into Regenerative Therapeutics - businesswire.com","headline":"RION names Biopharma Veteran Suneet Varma as Senior Advisor to Spearhead Expansion into Regenerative Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxQbXMxUWVlcjg1ZXgwRFJWeEJ0WHFLMUxXVzdmbzlNY1NsRFB0U0U4ZFg4OFdLdkdZRExDSHptLU9LdDRFV0lJNEMxN0RxeVFFQjdsdHVpa3AtNWFISUdWNC1IcEhMVDZnY1BFX1M2bGxCN3ZaN0oxRVNpeHRtZnZrZlFxYmM5WFJTQ1dlWlNtQWhzQXQ4dHJNSHV5ejFWVlpZX0NfRzNvdmo4YmFwNmMta0hxTVg0TXBqeWZOejhZVENOWVVrRklQZERzejZSYkllOW4zaTZmUmc0NC1keDhkMU9Qd3piX2xvMXBKYXpkU2gyNEwwd19Z?oc=5","date":"2025-01-13","type":"trial","source":"BioSpace","summary":"RION Announces Final Patient Enrolled in the Phase 2 Clinical Study for Purified Exosome Product™ (PEP™) in Diabetic Foot Ulcers - BioSpace","headline":"RION Announces Final Patient Enrolled in the Phase 2 Clinical Study for Purified Exosome Product™ (PEP™) in Diabetic Foo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNMEM0S2RNSkg5N2h3NExOWWF0ZFRkTlBFXzFiN2tfWGIyNUJaWkluQ3NsN3BrVE5xbEdaeHZNMFJkRjgtZVU4RU90eENnbmxSaFIyWjlkM0RGSTYwc1NRQUY3cHZxSGdnekNWR3BKWmZmWXphMHh1NlJlc0poSHBYOGxmdnU0YW9VeS05RDZvMDBkd2pHTVZDc2dwQ2IwdUQ3d1lfTkFENHd2N2ZuazVUQTJ0RUFGQjNXamRkM3JnZnRjVlJEYkJxcjRadVVNTTFWcFNPT2NCOFN4Rjh5ZGRJOVVpSW5TMkNjQ2Q0?oc=5","date":"2025-01-13","type":"trial","source":"PR Newswire","summary":"Exosome Therapies Market Poised for Explosive Growth During the Study Period (2025-2034) | DelveInsight - PR Newswire","headline":"Exosome Therapies Market Poised for Explosive Growth During the Study Period (2025-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOMEVOb2c3OF9VNmtMekdzR0E0UFVhbkxWVXVGUjE3MzZEZFNKTE5zc1JhMjZaRVU4MHJfMVdNRzN0elIxYUlKTU5Fc1VhTVVNcFRaWDZNR1lFZEMzQ2g5THZRTXBNVl82dTkzMTlhbVpYOVJndE8wQUNieHJ0UWNXQXNYdEZYYWs?oc=5","date":"2024-05-08","type":"trial","source":"Clinical Trials Arena","summary":"RION doses first subject in Phase IIa diabetic foot ulcer therapy trial - Clinical Trials Arena","headline":"RION doses first subject in Phase IIa diabetic foot ulcer therapy trial","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}